is retatrutide glp1 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗿𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲—𝗮𝗻𝗱 𝘄𝗵𝘆 𝗮𝗿𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝘀𝘁𝘂𝗱𝘆𝗶𝗻𝗴 𝗶𝘁? an investigational medication designed to act on three hormone pathways: GLP-1, GIP, and glucagon. Clinical research is exploring how GLP-1 vs Retatrutide for Fat

Future studies are expected to provide new insights

Where indicated, cells were pre-incubated with methyl- -cyclodextrin in advance of the assay before washing

10.1530/JOE-13-0525 155

Visceral adiposity, which leads to insulin resistance, is the putative mechanism in the development of diabesity, leading to insulin dependent Type 2 diabetes.2 The GLP-1 journey did not stop at treating Type 2 diabetes alone but has moved on to treating obesity, typically using higher dosing. THE RISE OF GLP-1 AGONISTS (INCRETIN MIMETICS) Along with newer classes of oral drugs for treating Type 2 diabetes such as DPP-IV (dipeptidyl peptidase-4) inhibitors and SGLT-2 (sodium-glucose co-transporter-2) inhibitors, the GLP-1 (glucagon-like peptide-1) receptor agonist drug class is being prescribed to combat Type 2 diabetes and to slow patient progression towards insulin dependency

Supernatant samples were named t20 and stored at 80 until dosage

FDA review timelines vary, and approval is not guaranteed until the regulatory process is complete